Healthcare provider profile · identity verified

Ryan Brower, M.D.

Family Practice · ELKHORN, WI · NPI 1497102347

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	734	190
Omeprazole	Omeprazole	381	80
Levothyroxine Sodium	Levothyroxine Sodium	357	76
Amlodipine Besylate	Amlodipine Besylate	346	86
Lisinopril	Lisinopril	327	93
Gabapentin	Gabapentin	322	83
Losartan Potassium	Losartan Potassium	296	81
Hydrochlorothiazide	Hydrochlorothiazide	274	80
Metformin Hcl	Metformin Hcl	226	56
Glipizide Er	Glipizide	212	55
Furosemide	Furosemide	210	60
Metformin Hcl Er	Metformin Hcl	207	56
Pantoprazole Sodium	Pantoprazole Sodium	204	49
Simvastatin	Simvastatin	195	42
Metoprolol Succinate	Metoprolol Succinate	191	48
Tamsulosin Hcl	Tamsulosin Hcl	186	50
Trazodone Hcl	Trazodone Hcl	150	28
Allopurinol	Allopurinol	147	38
Metoprolol Tartrate	Metoprolol Tartrate	134	33
Potassium Chloride	Potassium Chloride	134	42
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	132	31
Tramadol Hcl	Tramadol Hcl	126	27
Escitalopram Oxalate	Escitalopram Oxalate	125	29
Atenolol	Atenolol	114	22
Rosuvastatin Calcium	Rosuvastatin Calcium	112	31
Clopidogrel	Clopidogrel Bisulfate	110	28
Eliquis	Apixaban	107	24
Fluticasone Propionate	Fluticasone Propionate	101	30
Zolpidem Tartrate	Zolpidem Tartrate	91	18
Albuterol Sulfate Hfa	Albuterol Sulfate	90	42
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	86	20
Montelukast Sodium	Montelukast Sodium	85	14
Ipratropium Bromide	Ipratropium Bromide	83	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	83	15
Famotidine	Famotidine	82	18
Warfarin Sodium	Warfarin Sodium	82	24
Buspirone Hcl	Buspirone Hcl	80	18
Ketoconazole	Ketoconazole	75	26
Lorazepam	Lorazepam	73	17
Donepezil Hcl	Donepezil Hcl	71	13
Jardiance	Empagliflozin	71	22
Pravastatin Sodium	Pravastatin Sodium	71	19
Diclofenac Sodium	Diclofenac Sodium	70	41
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	69	16
Sertraline Hcl	Sertraline Hcl	67	17
Pregabalin	Pregabalin	61	15
Bupropion Hcl Sr	Bupropion Hcl	59	11
Tizanidine Hcl	Tizanidine Hcl	59	22
Alprazolam	Alprazolam	58	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	50	11
Breo Ellipta	Fluticasone/Vilanterol	48	suppressed
Finasteride	Finasteride	48	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	48	suppressed
Spironolactone	Spironolactone	47	11
Alendronate Sodium	Alendronate Sodium	46	suppressed
Mounjaro	Tirzepatide	46	suppressed
Clonazepam	Clonazepam	45	suppressed
Clonidine Hcl	Clonidine Hcl	45	12
Glimepiride	Glimepiride	45	14
Benazepril Hcl	Benazepril Hcl	43	11
Enalapril Maleate	Enalapril Maleate	43	13
Diazepam	Diazepam	42	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	42	26
Carvedilol	Carvedilol	41	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	41	36
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	41	suppressed
Baclofen	Baclofen	40	suppressed
Azithromycin	Azithromycin	39	32
Meloxicam	Meloxicam	39	suppressed
Glipizide	Glipizide	38	12
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	suppressed
Lovastatin	Lovastatin	37	suppressed
Ondansetron Odt	Ondansetron	36	23
Ozempic	Semaglutide	35	suppressed
Ramipril	Ramipril	35	suppressed
Ezetimibe	Ezetimibe	33	suppressed
Prednisone	Prednisone	33	21
Cephalexin	Cephalexin	29	26
Nystatin	Nystatin	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Synthroid	Levothyroxine Sodium	29	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	25
Citalopram Hbr	Citalopram Hydrobromide	28	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	27	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	27	21
Venlafaxine Hcl Er	Venlafaxine Hcl	27	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	26	11
Nyamyc	Nystatin	26	suppressed
Topiramate	Topiramate	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Duloxetine Hcl	Duloxetine Hcl	25	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	25	suppressed
Carbamazepine	Carbamazepine	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	suppressed
Chlorthalidone	Chlorthalidone	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Trimethoprim	Trimethoprim	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Sucralfate	Sucralfate	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Aripiprazole	Aripiprazole	20	suppressed
Hydralazine Hcl	Hydralazine Hcl	20	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	20	12
Memantine Hcl	Memantine Hcl	20	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Ibuprofen	Ibuprofen	18	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Hydrocortisone	Hydrocortisone	17	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Xarelto	Rivaroxaban	17	suppressed
Amoxicillin	Amoxicillin	16	11
Celecoxib	Celecoxib	16	suppressed
Propranolol Hcl Er	Propranolol Hcl	16	suppressed
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	16	suppressed
Bumetanide	Bumetanide	15	suppressed
Cholestyramine	Cholestyramine (With Sugar)	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Rybelsus	Semaglutide	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	11
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Mupirocin	Mupirocin	14	suppressed
Desmopressin Acetate	Desmopressin Acetate	13	suppressed
Imipramine Hcl	Imipramine Hcl	13	suppressed
Mibelas 24 Fe	Norethindrone-E.Estradiol-Iron	13	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	13	suppressed
Verapamil Hcl	Verapamil Hcl	13	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Januvia	Sitagliptin Phosphate	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Temazepam	Temazepam	12	suppressed
Torsemide	Torsemide	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Lansoprazole	Lansoprazole	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Potassium Citrate Er	Potassium Citrate	11	suppressed
Restasis	Cyclosporine	11	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error